The inner cell mass of pre-implantation blastocyst stage embryos is a source of cells that can be cultured indefinitely in vitro as a self-renewing, pluripotent population. In this review, we discuss the hallmarks of pluripotent cells derived from murine and human embryos and compare signaling pathways and transcriptional networks required to maintain them in a stable, pluripotent state. Culture conditions required for maintenance of murine and human embryonic stem cells (ESCs) vary significantly, but numerous 'critical' factors have been identified as being important for ESC pluripotency. We will attempt to reconcile the literature in terms of what is critical, from a signal transduction perspective, for maintenance of pluripotency. Finally, we consider recent findings describing a new pluripotent population of cells derived from the mouse epiblast, which seem to be more closely related to hESCs than mESCs. This poses some interesting questions as to the developmental equivalence of hESCs and suggests how we need to re-evaluate how we think of hESCs in the future.
The developmental origins of murine embryonic stem cells
At the early blastocyst stage of development, the mammalian embryo is comprised of three predominant cell populations. First, the trophectoderm (TE), which gives rise to extraembryonic tissues, such as placenta, which are critical for supporting embryonic development by facilitating exchange of nutrients and oxygen with the mother. 1, 2 The second is a ball of approximately 20 cells known as the inner cell mass (ICM). The ICM is comprised of pluripotent cells, which amplify rapidly during the epiblast stage of development and subsequently differentiate into the three embryonic germ layers (ectoderm, mesoderm and definitive endoderm)-the founders of all adult tissues. The ICM is surrounded by a third cell type known as primitive endoderm (PrEn). Formation of PrEn around the ICM denotes the epiblast stage of development, which extends until gastrulation 2 ( Figure 1 ). As the epiblast develops past the ICM stage to the egg cylinder stage (Figure 1 ), a cavity forms at the core of the pluripotent cells resulting in the formation of a single layer of pseudostratified epithelia known as primitive ectoderm (PrEct). Primitive ectoderm is pluripotent but represents a different stage of the pluripotent continuum that exists during pre-gastrulation development. As pluripotent cells commit toward one of the three germ layers, they lose pluripotency and just prior to or coinciding with this, the germ cells are segregated away into the allantois where they will preserve the germ line by migrating to the genital ridge.
Embryonic stem cells and pluripotency
Murine embryonic stem cells (ESCs) were first isolated in 1981 from blastocyst stage embryos 3, 4 and exhibit two remarkable features in culture. First, under the appropriate conditions, they can be propagated indefinitely as a stable self-renewing population where at every cell division, both mother and daughter cell retain stem-cell identity following a symmetric cell division. 5 This immortalized phenotype allows ESCs to be cultured over extended periods of time. Upon differentiation, this feature is lost and progeny succumb to cellular aging mechanisms (Hayflick limit) as has been well documented for all other non-transformed primary cells. This selfrenewing phenomenon seems to be developmentally regulated but it is not clear if it is inherently tied into the pluripotent state (this will be addressed in more detail later). A second feature of more developmental relevance is that during extended culture, ESCs retain their pluripotency and can differentiate into the same range of cell types as those formed in the embryo from the ICM. For the purposes of this discussion, we describe pluripotency as being the ability to generate all adult cell types and totipotency as the ability to form all adult, germ line and extra-embryonic tissues. The latter definition is usually reserved for fertilized eggs since ESCs can not contribute to TE or PrEn when injected into blastocysts, 6 but do differentiate into other lineages. 7, 8 A stringent test for the developmental potential for mESCs is their ability to contribute to the germ line and all tissues of an adult animal following injection into recipient blastocysts. A common alternate assay for ESC potency, particularly for hESCs where embryo transfer is not practical, is to inject ESCs into immunocompromised mice where they form mixed cell tumors known as teratomas. The ability of injected ESCs to generate a tumor comprising mesoderm, ectoderm and endoderm lineages is indicative of their multipotency.
While functional analysis of ESC developmental potential is the gold-standard for ESC analysis, molecular markers are often used as readouts for the stem-cell state because of practical issues. Many of these markers are transcription factors expressed in the ICM and ESCs and which have demonstrated roles in maintenance of ESCs and/or the ICM. The best-characterized examples include the POU domain transcription factor Oct3/4, 9 the homeodomain transcription factor Nanog 10,11 and the high-mobility group protein protein Sox2. 12 Transcription factor networks involved in ESC pluripotency have been reviewed elsewhere. 13, 14 Other signatures include high TERT expression and presentation of characteristic cell-surface antigens such as the glycomarker SSEA1, 15 the tetraspanin CD9 16 and the carbohydrate epitope N-acetylgalactosamine.
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Most of the transcription-factor regulatory networks responsible for maintenance of pluripotency appear to have been conserved between human and mouse ESCs and will be considered in greater detail later in this article. Striking differences do emerge however, when cell-surface markers of ESCs are compared. hESCs do not exhibit high SSEA1 reactivity, but instead are identified based on elevated SSEA3, -4 and TRA-1-60, TRA-1-81 antigens. [18] [19] [20] In contrast to mouse ESCs, N-acetylgalactosamine epitopes recognized by the lectin DBA are not a feature of hESCs (SD unpublished). The central question that again arises is: Are human and mouse ESCs representative of different stages of development or, are mouse and human pluripotent cells different in many respects? While human and murine ESCs pack tightly together and individual cells exhibit a high nuclear-tocytoplasmic volume ratio, gross morphological differences exist between the structures of ESC colonies. For example, mESCs grow as a three-dimensional domeshaped colonies whereas hESCs grow in colonies as thin layers, often monolayers. Self-renewal signals required for hESCs and mESCs maintenance are quite different and will be considered later in this review.
Isolation of pluripotent cells from mammalian embryos has clearly focused on the pre-implantation (ICM) stage of development where clear success has been obtained, resulting in the successful isolation of ESC-like cells from several species. Successful isolation of selfrenewing populations from post-implantation stages had not been successful until recently when two groups reported the isolation of stem cells from the murine latestage epiblast. 21, 22 Establishment of epiblast stem cells (EpiSCs) does not require the same cocktail of media components as for mESCs. Although EpiSCs can be maintained on mouse embryonic fibroblasts (MEFs) (as can mESCs and hESCs), a major difference between mESCs and EpiSCs is that under feeder-free conditions, mESCs have a requirement for IL6 family member cytokines such as leukemia inhibitory factor (LIF 23 ) to maintain self-renewal and pluripotency. This is not the case with EpiScs where LIF is not required. Moreover, the colony morphology of EpiSCs is more reminiscent of hESCs than mESCs since they grow as flat, epithelial colonies. In common with hESCs, EpiSCs have a requirement for Activin/Nodal signaling to promote self-renewal and they respond to bone morphogenetic protein-4 (BMP4) by differentiating into TE. 17 Although EpiSCs can differentiate into the three embryonic germ layers, their ability to contribute to the germ line has not been tested and so the differentiation capacity of these cells is yet to be fully characterized. These are very exciting findings and indicate that ICM is not the only embryonic stage from which self-renewing stem cells can be isolated. It should be pointed out that successful attempts have been made to isolate mESCs and hESCs Molecular and biological properties of pluripotent ESCs S Ohtsuka and S Dalton from different stages of pre-implantation stages of development, 24, 25 but not from post-implantation stages. The parallel between EpiSCs and hESC did not escape the authors' attention 21, 22 and the possibility that they represent a developmentally equivalent cell type was raised.
Signaling pathways required for murine ESC self-renewal
As elucidated briefly already, the signaling requirements for maintenance of human and murine ESCs differ considerably. Why should this be? We will discuss the literature and try to reconcile these differences by considering known signaling pathways implicated in ESC self-renewal (summarized in Figure 2 ).
The best-characterized effector of mESC self-renewal is LIF. LIF is a member of the IL6 family of cytokines that plays a key role in maintaining mESC self-renewal and functions by engaging the LIF/gp130 heterodimeric receptor, thereby recruiting and activating STAT3, a transcription factor that translocates to the nucleus and regulates genes required for 'stemness'. [26] [27] [28] While LIF can activate JAK-STAT3 and Ras-MAPK pathways in mESCs, studies in mice indicate that genetic inactivation of LIF signaling has no major effect on development. 29 This may be due to compensation by other IL6 family members, such as ciliary neurotrophic factor, which can also signal through LIF/gp130 receptors. 30 LIF/STAT3 seems to be important for maintenance of the blastocyst during delayed implantation, 29 although this is not relevant to human development. 30 Several efforts have been made to understand the mechanism of STAT3-dependent self-renewal in mESCs. [26] [27] [28] One of the most promising targets identified is the proto-oncogene c-myc, a helix-loop-helix transcription factor that is a direct transcriptional target of STAT3. 31 Following LIF withdrawal, c-myc transcript levels decrease due to inactivation of STAT3. Maintenance of myc levels using inducible transgenes can maintain self-renewal in the absence of LIF indicating that myc is a major target of the LIF-STAT3 self-renewal pathway in mESCs. 31 A second pathway that controls myc levels involves glycogen synthase kinase-3 (GSK3)-dependent phosphorylation. When LIF signaling ceases, GSK3 is rapidly activated and phosphorylates c-myc on threonine 58, triggering its ubiquitination and proteosome-dependent degradation. How GSK3 activity is suppressed in mESCs is unclear, but is likely to involve phosphatidylinositol 3 kinase (PI3K) activity either directly or indirectly as a consequence of LIF signaling. Another intriguing connection between GSK3 and selfrenewal was made when the efficiency of mESC derivation was shown to be markedly enhanced in the presence of BIO, a chemical inhibitor of GSK3. 32 Hence, low GSK3 activity could be an absolute requirement for pluripotency and ESC self-renewal.
A second pathway implicated in mESC self-renewal involves BMP signaling. Although BMP is generally not added as a recombinant factor, as in the case of LIF, BMP in fetal calf serum (FCS) appears to have a promaintenance effect at least under some culture conditions. 33, 34 Under these conditions, BMP acts by promoting Id gene expression, which serves to block neural differentiation. The report by Ying et al. 33 was the first to seriously raise the issue that self-renewal must be a coordinated series of events that involves maintenance of the pluripotent state and the blockade of differentiation pathways. In the case of BMP signaling, ectoderm specification is inhibited. By this model, other factors would work in collaboration with BMP to restrict differentiation pathways for mesoderm and endoderm. Qi et al. 34 have alternative explanations for how BMP impacts on mESCs self-renewal. In their experiments, they show that BMP blocks differentiation by suppressing p38 MAP kinase. 35 Since different laboratories use different culture conditions including FCS which is a huge variable, it seems likely that BMP contributes to suppression of differentiation by context-dependent mechanisms. The main outcome however, is to suppress pro-differentiation signaling pathways.
Phosphatidylinositol 3 kinase is involved in many aspects of cell behavior such as proliferation, apoptosis and differentiation. 36 A major effector of PI3K signaling is protein kinase B (PKB)/AKT1. There is a large body of 31 c-myc is also regulated negatively by glycogen synthase kinase-3 (GSK3)b via inhibitory phosphorylation. LIF also induces MAP kinase activation, which antagonizes self-renewal. BMP signals potentially function in two ways: (i) activation of Smad1/5/8-Id gene and (ii) suppression of p38 MAP kinase. Activin A has been shown to contribute mESCs proliferation but not pluripotency. (b) FGf2 is an essential factor for hESCs selfrenewal and functions in part at least by inducing Activin secretion from MEFs. Activin/Nodal signaling is essential to support hESCs self-renewal via activation of Smad2/3, resulting in upregulation of Nanog and Oct3/4 transcription. 51 In contrast to mESCs, BMP promotes hESCs differentiation toward trophectoderm.
17 PI3K-Akt pathway is also essential for hESC self-renewal although downstream effectors and targets have not been defined. BMP, bone morphogenetic protein; ESCs, embryonic stem cells; Fgf, fibroblast growth factor; LIF, leukemia inhibitory factor; MEFs, mouse embryonic fibroblasts.
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S Ohtsuka and S Dalton evidence demonstrating that PI3K signaling is crucial for mESC self-renewal. 37, 38 Inhibition of PI3K signaling by small molecule inhibitors such as LY294002 promotes differentiation even in the presence of LIF. 39 As mESCs differentiate, PI3K and AKT activities decline, consistent with this signaling pathways being important for selfrenewal. Sustained AKT activity, achieved by ectopic expression of a constitutively active mutant, significantly delays differentiation of murine and monkey ESCs. 40 Although PI3K/AKT seems to be crucial for mESC selfrenewal, the factors promoting their activity have not been clearly defined. Candidates include serum components such as insulin-like growth factor (IGF) or even LIF, a known activator of PI3K signaling through LIFgp130 receptor complexes. Mechanistically, PI3K/AKT may function by suppressing GSK3, a known antagonist of pro-self renewal regulators such as c-myc. 31, 41, 42 Increased ERK activity is though to be correlated with early differentiation of mESCs following LIF withdrawal and suppression of its activity by addition of PD98059 reduces the level of LIF required to maintain mESC selfrenewal. 43 LIF itself promotes ERK activity but this is balanced by self-renewal signals generated at the LIFgp130 receptor. Recent work indicates that fibroblast growth factor (Fgf)4 secreted by mESC primes cells for differentiation by acting through ERK and that suppression of this signal compromises differentiation. 35 In summary, LIF-STAT3 is critical for mESCs selfrenewal. In conjunction with additional signals in serum, self-renewal is promoted. Besides LIF, PI3K/AKT appears to be most critical, and may be activated as part of the LIF signaling pathway or from other factors in media (for example insulin, IGF). The absence of defined media formulations has compounded the definition of self-renewing signaling pathways in mESCs. Part of the problem relates back to the different culture conditions used by laboratories in the field and the nemesis of many tissue culture systems, variability in batches of FCS.
Signaling pathways required for hESC self-renewal
It did not take long for the field to realize that culture conditions required for mESC self-renewal are quite different to that required for hESC maintenance. Although human and murine ESCs can be maintained on MEF feeder layers in FCS (which has to be carefully batch tested), differences clearly emerge under feederfree conditions. LIF is clearly not required for hESC selfrenewal, 30 but instead several other factors have been identified such as Fgf2, Activin A and activators of PI3K signaling such as IGF/insulin.
From the onset of discussions relating to hESC culture, it should be clearly stated that first generation feeder-free conditions utilized MEF-CM, a complex mixture of secreted factors and FCS/synthetic serum-replacement formulations. The complexity of MEF-CM again raises question in terms of defining the critical factors. For example, Xu et al. 44 identified BMP activity in serumreplacement media associated with serum albumin. Clearly, there is a great need to progress toward defined media that can sustain hESC self-renewal independently of MEFs, serum and other undefined media components.
From the early experiments using MEF-CM, it was clear that supplementation with Fgf2 had profound effects on hESC stability. 45, 46 Since then, Fgf2 (basic Fgf; bFGF) has been consistently used in both MEF-CM-based and -defined media formulations for hESCs. Fgf2 may promote hESC self-renewal in two ways. First, by directly activating signaling pathways required for self-renewalperhaps through transcriptional networks (to be discussed below). Second, it could work indirectly by stimulating autocrine effects. Since Fgf2 is added at the time of MEFmedia conditioning, it may serve to promote secretion of factors from MEFs. 47 Since Fgf2 is a key component of defined media, where MEFs and MEF-CM are absent, the first possibility certainly seems likely.
Members of the transforming growth factor-b family such as Activin A also seem to play a role in maintaining hESC self-renewal perhaps in collaboration with Fgf2. 48, 49 This may involve a mechanism where Activin A signals directly through Smads to promote transcription of genes encoding transcription factors required for self-renewal such as Nanog and Oct3/4. 50 In contrast, Activin A does not appear to be involved in mESC selfrenewal 51 and would probably interfere with BMPdependent self-renewal pathways in this system because of reciprocal antagonism. 52 In contrast to the situation in mESCs, BMP promotes differentiation into hESCs 53 and antagonism of BMP signaling by growth differentiation factor-3 can promote hESC self-renewal. 54 Evidence is emerging that PI3K signaling is crucial for hESCs self-renewal. We previously showed that for specification signals such as Activin A to promote hESCs differentiation, PI3K signaling must first be inactivated. 55 Although the mechanism for this has not been resolved, it appears that PI3K antagonizes signaling pathways required for cell-fate commitment as well as by promoting self-renewal regulatory circuits. In the case of Activin A-dependent definitive endoderm specification, PI3K can be suppressed by chemical inhibitors such as LY 29402 or by removing/reducing FCS or serum supplements. 55, 56 Removal of insulin/IGF type molecules seems to be important for reducing PI3K signaling in this context. Addition of PI3K agonists such as IGF and insulin to defined media formulations would therefore play two roles: (i) promote self-renewal by suppressing differentiation and (ii) promote cell survival. Another anticipated outcome of PI3K signaling would be to suppress GSK3 activity. This is consistent with reports from Sato et al., 42 who showed that suppression of GSK3 is central to hESCs self-renewal in short-term assays.
In contrast to what has been described for mESCs, ERK activity is inhibited during hESCs differentiation when cells are cultured in MEF-CM. 57, 58 This raises questions about the generality of ERK in self-renewal/ differentiation and it is unclear if these differences represent differences between species, culture conditions or whether this can be attributed to hESCs and mESCs representing different phases of development.
Now that defined media formulations are being widely used to propagate hESCs, the key growth factors and signaling pathways are now being revealed. Activin A, Fgf2 and insulin/IGF seem to be the consensus players revealing key roles for Smad, PI3K signaling and possibly ERK signaling in hESC self-renewal. This clearly portrays a different picture to that which has emerged from studies on mESCs.
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Cell-cycle control in ESCs
Perhaps one of the most-striking features of mESCs is their mode of cell-cycle control. To place this in context, it is important to understand cell division in the periimplantation stages of mouse development. Just preceding gastrulation, pluripotent cells of the epiblast have a cell-cycle length of B6 h. 61 Once differentiation into the embryonic germ layers occurs, this rate of cell division slows down dramatically (420 h 62, 63 ). Similar changes in cell-cycle dynamics occur as ESCs differentiate, indicating that cell-cycle changes are intimately associated with loss of pluripotency. [62] [63] [64] [65] Pluripotent cells divide rapidly since they do not spend appreciable amounts of time in G1 phase. As cells exit mitosis, they commit to DNA replication without a significant G1 delay period that is normally devoted to cell growth and integration of mitogenic signals. Consequently, ESCs spend B65% of their time in S phase because of the very short periods of time devoted to the gap phases. Differentiation is associated with increased generation times and the establishment of a fully formed G1 phase. At the molecular level, this has an intriguing basis. mESCs exhibit elevated, constitutively active Cdk activities. 63 Most notably, Cdk2-cyclin E is not under cell-cycle control until cells differentiate-in part due to changes in the expression of Cdk inhibitors such as p16
INK4a p27
Kip1 and p21 cip1 . The only Cdk complex under cell-cycle control in mESCs is Cdk1-cyclin B. The constitutive activity of Cdk complexes results in hyperphosphorylation of Rb family members and constitutive transcription of E2F target genes. By definition, pluripotent cells do not have an intact restriction (R-) point and only acquire one as part of a developmental program associated with gastrulation/cell-fate commitment. 62 Detailed molecular characterization of the cell-cycle machinery has not been performed in hESCs but they do exhibit a similar cell-cycle structure to mESCs, with an S-phase fraction of B50-60%. 62 hESCs however, cycle much more slowly than mESCs with generation times of 30-38 h being common. The reasons for this are not clear but are likely to reflect differences in the absolute levels of Cdk activities. It should be emphasized that no evidence to date has directly linked this unusual mode of cell-cycle regulation in the embryo or ESCs to the pluripotent state.
Transcriptional networks that control pluripotency
A network of transcription factors including Oct3/4, Nanog and Sox2 have been shown to be crucial for development of pluripotent cells in the peri-implantation embryo and for maintenance of pluripotency of human 66, 67 and murine ESCs. [68] [69] [70] This has been the subject of numerous reviews and so we refer the reader to some of these articles. 13, 14, 71 However, a few important features of this network will be briefly discussed. First, chromatin immunoprecipitation, on chip array analysis indicates that Oct3/4, Nanog and Sox2 appear to work together in protein complexes by binding promoters of genes that are expressed and repressed. 67 The interpretation of these findings is that these transcription factors activate genes required for self-renewal and repress other genes required for differentiation. It should be mentioned however, that functional validation of this hypothesis has not been definitively provided. Another major unknown is how the activity of these factors is controlled in the self-renewing state. Presumably, signaling pathways required for self-renewal sustain Oct3/4, Nanog and Sox2 expression but how this occurs is a mystery.
Takahashi et al. 72 recently showed that coexpression of four transcription factors by retroviral transduction could dedifferentiate MEFs back to an ESC-like state. 72 The factors required were Sox2, Oct3/4, the Kruppel-like factor 4 (Klf4) and c-myc. Nanog was not required for dedifferentiation but its expression was re-established by the four named factors. Further investigation showed that Sox2 is dispensable so long as Oct3/4 levels are elevated further. 73 How could these factors participate in re-establishment of an ESC-like state? c-myc for example is known to be a global gene regulator and plays an active role in gene activation and repression. 74 In particular, it is known to promote global acetylation of chromatin. 75 Establishing an open chromatin state by enhanced histone acetylation could then facilitate complexes of Oct3/4, Sox2 and Klf4 to bind target genes required for establishment and maintenance of pluripotency. Similar experiments could not reproduce this effect in human cells however.
In summary, genetic and biochemical analysis has established a role for Oct3/4, Nanog, Sox2, c-myc and Klf4 in ESC cell identity. However, how the transcription factors co-operate on reprogramming event needs to be addressed.
Conclusions and perspectives
Understanding the mechanisms that promote self-renewal of pluripotent cells is crucial if we are to harness the full potential of this therapeutically useful cell type. Investigators have been trying to solve the question of how ESCs retain their self-renewing capacity for more than 10 years, but several major questions still need to be addressed. It is still not understood how cell-signaling pathways involved in this process integrate with the core self-renewal machinery. How does LIF signaling impact on Oct4 expression in mESCs and how does Fgf2 impact on Nanog in hESCs? In mouse, LIF-STAT3 signaling targets c-myc, but beyond this there are few validated targets of this pathway that could give clues as to how self-renewal is maintained. In human ESCs, Activin A seems to regulate Nanog transcription but a full picture of self-renewal at the molecular level is yet to be obtained. Hints as to how the transcription network in ESCs functions on a global scale, however, are now beginning to emerge. Genome-wide studies point toward interactions between Sox2, Nanog and Oct3/4 on target promoters, involving context-dependent activation or repression. The full details of this still need to be rigorously evaluated and much of the global analysis needs to be functionally validated. This and the area of epigenetic regulation in ESCs form fertile ground that needs to be explored further.
Perhaps the major factor confounding the field is due to variability in culture conditions between different laboratories. The complexity of signaling components truly reflects the true nature of self-renewal in culture-a Molecular and biological properties of pluripotent ESCs S Ohtsuka and S Dalton balancing act where different signaling pathways need to be juggled. There appear to be several ways of balancing the self-renewal equation but ultimately, culture conditions must suppress differentiation and promote continued cell division. In the case of hESCs, many of these problems will be circumvented by the use of defined media where purified, recombinant growth factors are being used. Perhaps, the most provocative observation made over the last year is that hESCs may reflect a later stage of embryonic development than the ICM. Similarities between EpiSCs and hESCs confirm suspicions that many in the field have held for a long time-that while pluripotent, hESCs are not the developmental equivalent of mESCs. This may explain many of the differences between mouse and human ESCs that inexplicably have accumulated in the literature over the last 5 years. Perhaps this will lead to new efforts directed toward derivation of new hESC cell lines representing alternate stages of pre-implantation development.
